<DOC>
	<DOC>NCT01299532</DOC>
	<brief_summary>This is an open, multi-center, non comparative study to evaluate the safety and efficacy of Macrolane VRF30 in the female breast. 71 subjects have received initial treatment with a maximum of 120 ml of Macrolane VRF30 per breast. 22 patients have received a re-injection (max 120 ml/breast) of Macrolane nine months after initial treatment. Patients are followed for 24 months after last treatment.</brief_summary>
	<brief_title>Macrolane VRF30 for Enhancement of Shape and Fullness of Female Breast</brief_title>
	<detailed_description />
	<criteria>Patients between 25 and 60 years with small breasts seeking enhancement of the shape and fullness of the breast Unreasonable expectations as regards the increase in breast volume Any medical conditions that may interfere in any way.</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>